Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II Study)

Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: Insights from the Canadian Trial of Atrial Fibrillation (CTAF)

(2011) Maryse Palardy et al.   CANADIAN JOURNAL OF CARDIOLOGY

Progression From Paroxysmal to Persistent Atrial Fibrillation

(2010) Cees B. de Vos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition

(2010) Markus P. Schneider et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Antihypertensive Treatment With ACE Inhibitors or  -Blockers and Risk of Incident Atrial Fibrillation in a General Hypertensive Population

(2009) S. R. Heckbert et al.   AMERICAN JOURNAL OF HYPERTENSION

Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women

(2009) David Conen et al.   CIRCULATION

Optimal Treatment Strategy for Patients With Paroxysmal Atrial Fibrillation

(2009) Satoshi Ogawa et al.   CIRCULATION JOURNAL

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management

(2009) M. Nabauer et al.   EUROPACE

Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)

(2009) L. Julian Haywood et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Valsartan for Prevention of Recurrent Atrial Fibrillation

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Blood Pressure Control and Risk of Incident Atrial Fibrillation

(2008) M. C. Thomas et al.   AMERICAN JOURNAL OF HYPERTENSION

Effect of Valsartan and Ramipril on Atrial Fibrillation Recurrence and P-wave dispersion in Hypertensive Patients With Recurrent Symptomatic Lone Atrial Fibrillation

(2008) R. Fogari et al.   AMERICAN JOURNAL OF HYPERTENSION

Prevention of Recurrent Lone Atrial Fibrillation by the Angiotensin-II Converting Enzyme Inhibitor Ramipril in Normotensive Patients

(2008) Fabio Belluzzi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Role of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Aldosterone Antagonists in the Prevention of Atrial and Ventricular Arrhythmias

(2008) Kathy M Makkar et al.   PHARMACOTHERAPY